Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories
By AmerisourceBergen
Launches in ophthalmology and the first interchangeable insulin biosimilar in the U.S. bring new opportunities for this exciting product class. Listen in as our experts discuss these developments.
